Focus on manager missions and spend on your squad to get off to the perfect start in Sega Football Club Champions.

The 2026 SPE International Polyolefins Conference announces Keynote Speakers and the Program ...

Sterile compounding has long been recognized as a high-risk area of health system pharmacy. Traditional manual IV compounding techniques can be prone to human error, leading to incorrect ingredients ...

Springfield will regain its compounding pharmacy soon with the opening of RxAvenue inside of the former Madison Avenue Pharmacy space. RxAvenue will open after the owners complete the compliance and ...

Investment gains achieved on small-but-steady savings will eventually eclipse your annual contributions of new money. Most of these gains, however, are only achieved near the end of your savings time ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

Pharmacy compounding is one of the topics in the EU Pharma Law Package that has perhaps received less attention compared to topics such as regulatory exclusivity rights, shortages, and sustainability.

Add Yahoo as a preferred source to see more of our stories on Google. A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved ...

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...

Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent implosion of Novo’s partnership with telehealth firm Hims & Hers suggests there is ...